Gregg H. Alton Sells 15000 Shares of Gilead Sciences, Inc

The stock decreased 1.23% or $0.74 during the last trading session, reaching $59.2. About 616,114 shares traded. It is down 21.80% since December 7, 2016 and is downtrending. It has outperformed by 25.59% the S&P500.

Com (GILD) stake by 51.69% reported in 2017Q2 SEC filing. The Neville Rodie & Shaw Inc holds 42,130 shares with $2.98M value, down from 55,146 last quarter.

In other Gilead Sciences news, insider John C. Martin sold 73,333 shares of Gilead Sciences stock in a transaction that occurred on Monday, October 2nd. It has underperformed by 38.50% the S&P500. Vetr raised shares of Gilead Sciences from a "hold" rating to a "buy" rating and set a $89.27 price target on the stock in a report on Wednesday, September 6th.

COPYRIGHT VIOLATION WARNING: "FIL Ltd Buys 1,980 Shares of Gilead Sciences, Inc". The firm has "Buy" rating given on Wednesday, February 3 by Standpoint Research. The firm has "Buy" rating by Maxim Group given on Thursday, November 30. Mizuho has "Buy" rating and $7700 target. The stock of Gilead Sciences, Inc.

With a change of 0.27% the price for GILD is 73.29. Captrust Finance Advsrs has invested 0.07% in Gilead Sciences, Inc. The firm earned "Equal-Weight" rating on Friday, October 2 by Morgan Stanley. The company was maintained on Wednesday, October 4 by Jefferies. The investor is now holding 27,711,666 shares thanks to an increase of 4,674,363 new shares in their portfolio. Its down 0.12, from 0.91 in 2017Q1.

A number of other institutional investors have also bought and sold shares of GILD. The biopharmaceutical company reported $2.27 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.13 by $0.14. Cordasco Financial Network holds 600 shares or 0.05% of its portfolio. Institutional investors and hedge funds own 76.23% of the company's stock. Altavista Wealth Mgmt reported 0.13% stake. Shelter Mutual Ins stated it has 80,900 shares. Harel Insurance Investments & Financial Services Ltd. now owns 1,640 shares of the biopharmaceutical company's stock valued at $110,000 after buying an additional 1,400 shares during the period. Stockholders of record on Friday, December 15th will be issued a dividend of $0.52 per share. (NASDAQ:GILD). The New York-based Shufro Rose And Limited Liability Co has invested 0.04% in Gilead Sciences, Inc. (NASDAQ:GILD). Wealthtrust accumulated 63 shares. 26,391 are held by Eagle Asset Mgmt. Croft reported 58,854 shares. Acadian Asset Limited Com stated it has 0% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD) rating on Tuesday, July 25. Moreover, Main Street Rech Ltd Liability Corp has 0.07% invested in Gilead Sciences, Inc. (NASDAQ:GILD). Raymond James Finance Ser Advsr has 0.14% invested in Gilead Sciences, Inc. (NASDAQ:GILD) rating on Wednesday, November 2. Gilead Sciences had 107 analyst reports since July 29, 2015 according to SRatingsIntel.

GILD has been the subject of a number of analyst reports. They expect $0.54 EPS, up 5.88% or $0.03 from last year's $0.51 per share. (GILD) worth $2.03 billion at the end of the most recent reporting period. Vanguard Group Inc. increased its stake in shares of Gilead Sciences by 2.4% during the second quarter.

Since January 1, 0001, it had 0 insider buys, and 1 insider sale for $283,270 activity. The insider Lewnes Ann sold 2,233 shares worth $311,035.

Investors sentiment decreased to 0.79 in Q2 2017.

The (Simple Month Average) SMA20 is at 0.53 percent, its SMA50 Value is -4.97% and SMA200 value is reported as 1.36 Percent. Bokf Na accumulated 49,392 shares. 117 funds opened positions while 294 raised stakes. 188.94 million shares or 14.20% more from 165.44 million shares in 2017Q1 were reported. Usca Ria Limited Liability Co reported 0.05% stake. Moreover, Pinebridge Investments Limited Partnership has 0.54% invested in Adobe Systems Incorporated (NASDAQ:ADBE) for 147,345 shares. Its revenue stood at 1.60% a year on average in the period of last five years. 281,155 were reported by Ig Mgmt Ltd. Rodgers Brothers holds 11,475 shares or 0.3% of its portfolio.

Analysts often look at short interest, or the number of shares now being shorted by investors, to aid in their outlook for a particular stock. Commerce Fincl Bank owns 52,094 shares. Comerica National Bank & Trust holds 449,500 shares. 30,246 were reported by Virtus Invest Advisers. State Bank owns 32,278 shares. (NYSE:UAL). The Alabama-based Tillar has invested 1.72% in United Continental Holdings, Inc.

D L Carlson Investment Group Inc increased Johnson & Johnson (NYSE:JNJ) stake by 23,688 shares to 74,704 valued at $9.88 million in 2017Q2. Vanguard Bd Index Fd Inc (BND) was raised too. Looking out over a next 5-year period, analysts expect the company to see its earnings go up by -12.39%, annually. UAL's profit will be $284.42M for 16.14 P/E if the $0.96 EPS becomes a reality. (NYSE:TCO) to report earnings on February, 8. One equities research analyst has rated the stock with a sell rating, eleven have issued a hold rating, nineteen have assigned a buy rating and one has given a strong buy rating to the stock. Therefore 71% are positive. Leerink Swann has "Mkt Perform" rating and $94 target. TheStreet upgraded shares of Gilead Sciences from a "c+" rating to a "b-" rating in a research note on Thursday, September 7th. The company was upgraded on Tuesday, December 6 by Bank of America. The rating was maintained by Mizuho with "Buy" on Monday, February 13. Jefferies maintained ONEOK, Inc. Jefferies has "Buy" rating and $180 target.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.



Other news